Put Options

11 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.32 - $7.33 $844,816 - $1.16 Million
158,800 New
158,800 $1.16 Million
Q1 2022

May 17, 2022

SELL
$10.05 - $22.48 $1.04 Million - $2.33 Million
-103,800 Reduced 20.76%
396,300 $4.91 Million
Q4 2021

Feb 15, 2022

SELL
$17.78 - $33.08 $1.35 Million - $2.51 Million
-75,800 Reduced 13.16%
500,100 $11.4 Million
Q3 2021

Nov 16, 2021

BUY
$10.93 - $23.55 $2.16 Million - $4.66 Million
197,700 Added 52.27%
575,900 $12.7 Million
Q2 2021

Aug 16, 2021

BUY
$10.0 - $14.52 $3.51 Million - $5.09 Million
350,500 Added 1265.34%
378,200 $4.9 Million
Q1 2021

May 18, 2021

SELL
$12.3 - $18.73 $2.14 Million - $3.26 Million
-174,000 Reduced 86.27%
27,700 $360,000
Q4 2020

Feb 17, 2021

BUY
$12.94 - $16.05 $2.05 Million - $2.54 Million
158,400 Added 365.82%
201,700 $2.79 Million
Q3 2020

Nov 17, 2020

SELL
$13.19 - $16.66 $203,126 - $256,564
-15,400 Reduced 26.24%
43,300 $638,000
Q2 2020

Aug 17, 2020

BUY
$14.12 - $18.33 $665,052 - $863,342
47,100 Added 406.03%
58,700 $954,000
Q1 2020

May 15, 2020

SELL
$11.34 - $21.46 $269,892 - $510,748
-23,800 Reduced 67.23%
11,600 $168,000
Q4 2019

Feb 14, 2020

BUY
$3.88 - $21.42 $137,352 - $758,268
35,400 New
35,400 $717,000

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.15B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.